Revance Therapeutics (RVNC) Provides Update on RT001 Clinical Program
Tweet Send to a Friend
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced that the company has initiated a study to confirm this quarter the successful ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE